Company Analysis
Sign in

Nexalin Technology, Inc. (NXL)

Nasdaq: NXL · Electromedical & Electrotherapeutic Apparatus · Houston, TX · filing with the SEC since 2011
Full chart Alerts Compare
Grade3.7
◀ Past 3.0● Present 2.5▶ Future 6.0
2 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020
Report filedMar 25, 2026Mar 14, 2025Mar 27, 2024Mar 27, 2023··
Revenue301,647168,721110,7481,321,357144,065·
For lenders
Net interest income-8,240-3,19338,835···
Cost of revenue61,37336,59325,688363,21221,442·
Gross profit240,274132,12885,060958,145122,623·
Research and development1,083,5221,190,8841,921,811r511,000139,000·
Selling, general and administrative4,398,2414,228,9861,897,031r1,491,7395,215,423·
General and administrative3,132,7232,553,4592,367,821···
Total operating expenses8,631,1557,886,7745,781,3562,791,1766,141,224·
Operating income-8,390,881-7,754,646-5,696,296-1,833,031-6,018,601·
Interest expense-8,240-3,19338,83559,38282,319·
Total non-operating income (expense)169,748142,6131,047,587135,215-59,403·
Income before income taxes-8,221,133-7,612,033-4,648,709···
Net income including non-controlling interests-8,222,181-7,607,182-4,648,709···
Net income-8,222,181-7,607,182-4,648,709-1,697,816-6,078,004·
Earnings per share, basic-0.50-0.83-0.63-0.30··
Earnings per share, diluted-0.50-0.83-0.63-0.30··
Weighted average shares, basic16,392,4659,215,7727,357,0295,572,402··
Weighted average shares, diluted16,392,4659,215,7727,357,0295,572,402··
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:Revenues
Net interest income interest earned less interest paidus-gaap:InterestIncomeExpenseNet
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfRevenue
Gross profit revenue less the cost of what it soldus-gaap:GrossProfit
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
SI Assistanton NXL · research, not advice